Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerance and efficacy of Liposomal
Paclitaxel With Nedaplatin as First-line in patients with Advanced or Recurrent Esophageal
Carcinoma